Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest

Lisa Schaeffera Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyView further author information

Nesrine Ben-Anayaa Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyCorrespondence[email protected]
View further author information

Christina Sorbea Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyView further author information

Stephan Jeff Rustenbacha Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyView further author information

Ulrich Mrowietzb Psoriasis Centre, Clinic for Dermatology, University Medical Centre Schleswig-Holstein, Campus Kiel, GermanyView further author information

Matthias Augustina Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyView further author information

Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date